GIORDANO, Paola
 Distribuzione geografica
Continente #
NA - Nord America 19.512
EU - Europa 9.873
AS - Asia 8.669
SA - Sud America 2.572
AF - Africa 400
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 7
Totale 41.058
Nazione #
US - Stati Uniti d'America 19.176
SG - Singapore 3.731
IT - Italia 3.096
BR - Brasile 2.064
CN - Cina 1.866
DE - Germania 1.613
FR - Francia 1.241
HK - Hong Kong 1.097
SE - Svezia 1.004
RU - Federazione Russa 878
VN - Vietnam 546
UA - Ucraina 539
FI - Finlandia 525
GB - Regno Unito 503
IN - India 288
BD - Bangladesh 203
AR - Argentina 167
CA - Canada 151
IQ - Iraq 124
TR - Turchia 101
ID - Indonesia 98
CI - Costa d'Avorio 96
ZA - Sudafrica 94
MX - Messico 92
EC - Ecuador 86
PK - Pakistan 84
IE - Irlanda 81
CO - Colombia 72
NL - Olanda 69
VE - Venezuela 64
UZ - Uzbekistan 60
PL - Polonia 54
BE - Belgio 51
JP - Giappone 50
SA - Arabia Saudita 49
KR - Corea 46
MA - Marocco 45
PY - Paraguay 45
ES - Italia 42
AT - Austria 40
PH - Filippine 40
CL - Cile 33
KE - Kenya 31
MY - Malesia 29
AE - Emirati Arabi Uniti 28
TN - Tunisia 27
IL - Israele 23
EG - Egitto 22
JO - Giordania 22
LT - Lituania 21
AU - Australia 20
CZ - Repubblica Ceca 18
AZ - Azerbaigian 17
KZ - Kazakistan 17
PE - Perù 17
IR - Iran 16
OM - Oman 16
LB - Libano 15
DZ - Algeria 14
JM - Giamaica 13
PS - Palestinian Territory 13
TH - Thailandia 13
BO - Bolivia 12
CR - Costa Rica 12
DO - Repubblica Dominicana 12
NP - Nepal 12
PT - Portogallo 12
RO - Romania 11
CH - Svizzera 10
GE - Georgia 10
PA - Panama 10
UY - Uruguay 10
ET - Etiopia 9
HN - Honduras 9
AO - Angola 8
BG - Bulgaria 8
GR - Grecia 8
RS - Serbia 8
BH - Bahrain 7
KW - Kuwait 7
TT - Trinidad e Tobago 7
KG - Kirghizistan 6
MG - Madagascar 6
NG - Nigeria 6
SK - Slovacchia (Repubblica Slovacca) 6
SN - Senegal 6
GT - Guatemala 5
LY - Libia 5
NI - Nicaragua 5
NZ - Nuova Zelanda 5
SV - El Salvador 5
SY - Repubblica araba siriana 5
AL - Albania 4
BT - Bhutan 4
BY - Bielorussia 4
HR - Croazia 4
HU - Ungheria 4
KH - Cambogia 4
TW - Taiwan 4
AM - Armenia 3
Totale 40.969
Città #
Singapore 1.885
Fairfield 1.755
Ashburn 1.697
Woodbridge 1.526
Chandler 1.479
Jacksonville 1.271
San Jose 1.124
Hong Kong 1.090
Milan 965
Houston 949
Cambridge 797
Nyköping 757
Seattle 699
Wilmington 599
Ann Arbor 565
Beijing 463
Lawrence 392
Roxbury 390
Nanjing 362
Bari 360
Lauterbourg 358
New York 315
Rome 305
Des Moines 247
Dallas 244
Los Angeles 240
Boardman 206
Helsinki 191
Ho Chi Minh City 179
São Paulo 160
Princeton 159
Santa Clara 148
Inglewood 136
Buffalo 125
Hanoi 125
Munich 117
Council Bluffs 111
Brooklyn 110
San Diego 105
Abidjan 96
Chicago 96
Nanchang 88
Jiaxing 85
Figino 83
Shenyang 80
Hebei 79
London 75
Dublin 74
Turin 72
Columbus 69
Rio de Janeiro 67
Dearborn 62
Paris 57
Frankfurt am Main 56
Moscow 54
Baghdad 51
Brussels 49
Tashkent 49
Belo Horizonte 47
Johannesburg 43
Orem 43
Tianjin 43
Tokyo 43
Montreal 41
Naples 41
Warsaw 41
Redwood City 40
Changsha 39
Atlanta 37
Chennai 37
Nuremberg 37
Brasília 36
Jakarta 36
Salt Lake City 35
Dhaka 34
Romola 34
San Francisco 34
Bologna 32
Phoenix 32
Porto Alegre 32
Quito 32
Guangzhou 31
Pune 31
Curitiba 30
Denver 30
Toronto 30
Shanghai 28
Mexico City 27
Nairobi 27
Amsterdam 24
Boston 24
Campinas 24
Florence 24
Falkenstein 23
Lahore 23
Manchester 23
Modugno 23
The Dalles 23
Ankara 22
Genoa 22
Totale 25.406
Nome #
Correzione dell'ipofibrinogenemia acquisita con concentrato di fibrinogeno in bambini affetti da LLA in trattamento con Asparaginasi. L'esperienza di due centri AIEOP 505
Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Potential Diagnostic Biomarkers in Autism Spectrum Disorders: A Preliminary Study 284
Endothelial and Metabolic Function Interactions in Overweight/Obese Children. 267
Association between miRNAs expression and cognitive performances of Pediatric Multiple Sclerosis patients: A pilot study 248
Combined microRNA and mRNA expression analysis in pediatric multiple sclerosis: an integrated approach to uncover novel pathogenic mechanisms of the disease. 245
A Narrative Approach to Describe QoL in Children With Chronic ITP 196
Consensus statements on vaccination in patients with haemophilia-Results from the Italian haemophilia and vaccinations (HEVA) project 195
Cognitive, emotional, and behavioral profile in children and adolescents with chronic pain associated with rheumatic diseases: A case-control study 190
Can Anti-Thyroid Antibodies Influence the Outcome of Primary Chronic Immune Thrombocytopenia in Children? 183
Association of congenital afibrinogenemia and k-dependent protein C deficiency - a case report 176
How Physical Activity across the Lifespan Can Reduce the Impact of Bone Ageing: A Literature Review. 176
Authors' Reply to "CD10 in the Cytological Diagnosis of Endobronchial Endometriosis" 175
Serum D vitamin levels in children with immune thrombocytopenia 175
Non-alcoholic fatty liver disease is associated with early left ventricular dysfunction in childhood acute lymphoblastic leukaemia survivors. 175
Vascular Function and Myocardial Performance Indices in Children Born Small for Gestational Age. 172
Lupus anticoagulant, anticardiolipin antibodies and hepatitis C virus infection in thalassaemia 171
Using pharmacokinetics for tailoring prophylaxis in people with hemophilia switching between clotting factor products: A scoping review 171
Analysis of Circulating Mediators of Bone Remodeling in Prader-Willi Syndrome 168
APC Resistance in thalassemic patients and under-lying cause of thrombosis 166
Idiopathic neutropenia of infancy: Data from the Italian Neutropenia Registry 163
A polycentric, randomized, parallel-group, study on Lertal®, a multicomponent nutraceutical, as preventive treatment in children with allergic rhinoconjunctivitis: phase II 163
Metabolic syndrome in childhood leukemia survivors: a meta-analysis 161
Thromboembolic risk in children with nephrotic syndrome 159
Alagille syndrome: A novel mutation in JAG1 gene 158
Lupus anticoagulant, anticardiolipin antibodies and hepatitis C virus infection in thalassaemia 157
B-cell hyperfunction in children with immune thrombocytopenic purpura persists after splenectomy 157
Uric acid: from a biological advantage to a potential danger. A focus on cardiovascular effects 157
Pain assessment and management in haemophilia: A survey among Italian patients and specialist physicians 157
Von Willebrand factor and factor XIII in children with Henoch-Schonlein purpura 156
Carotenoids and Cardiovascular Risk 156
Alterazioni coagulative e fibrinolitiche nel neonato pretermine affetto da: IRDS, asfissia alla nascita, sepsi 156
The role of endothelial dysfunction and oxidative stress in cerebrovascular diseases 156
A volleyball player with bilateral knee osteochondritis dissecant treated with extracorporeal shock wave therapy 155
A practical approach to the use of low molecular weight heparins in VTE treatment and prophylaxis in children and newborns. 155
Porpora trombocitopenica idiopatica (immune) (PTI) acuta in età pediatrica.Linee guida AIEOP per la diagnosi ed il trattamento 155
Vaccine administration and the development of immune thrombocytopenic purpura in children 154
APC resistance in thalassemic patients:an under-lying cause of thrombosis 153
Cardiovascular dysfunction and vitamin D status in childhood acute lymphoblastic leukemia survivors 153
Are all cases of paediatric essential thrombocythaemia really myeloproliferative neoplasms? Analysis of a large cohort 152
New data from the Italian National Register of Congenital Coagulopathies, 2016 Annual Survey 151
Coagulation inhibitors (protein C and antithrombin III) in the preterm infant during the first month of life 150
Creazione del network italiano Asplenia per la gestione coordinata a livello nazionale dei pazienti asplenici: il ruolo dell'AIEOP e di altre società scientifiche 149
Uniparental disomy and pretreatment IGF-1 may predict elevated IGF-1 levels in Prader-Willi patients on GH treatment 148
Endothelial dysfunction and cardiovascular risk factors in childhood acute lymphoblastic leukemia survivors Autori 147
Alterazioni delle cellule B della memoria nella piastrinopenia idiopatica 146
Risk factors for subclinical atherosclerosis in diabetic and obese children 144
Effect of eradication of Helicobacter pylori in children with chronic immune thrombocytopenia: a prospective, controlled, multicenter study. 144
Afibrinogenemia congenita associata a deficit di PC K-dipendente 144
DETERMINATION OF von WILLEBRAND FACTOR AND FACTOR XIII IN CHILDREN WITH SCHONLEIN HENOCH SYNDROME 142
Issues in pediatric haemophilia care 142
Human Fibrinogen Concentrate and Fresh Frozen Plasma in the Management of Severe Acquired Hypofibrinogenemia in Children with Acute Lymphoblastic Leukemia: Results of a Retrospective Survey 142
Thrombin generation in children with acute lymphoblastic leukemia (ALL): effects of ALL immunophenotypic subgroup on inherited thrombotic risk factors 141
Hereditary hemorrhagic telangiectasia: arteriovenous malformations in children. 141
Covid-19 and children with immune thrombocytopenia: Emerging issues 141
Metabolic, inflammatory, endothelial and haemostatic markers in a group of Italian obese children and adolescents 139
Afibrinogenemia congenita associata a deficit di PC K-dipendente 139
Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: a communication from the Platelet Physiology SSC 139
Impact of sleep respiratory disorders on endothelial function in children. 138
Neonatal bacterial meningitis: a systematic review of European available data 138
Bodyweight-adjusted rivaroxaban for children with venous thromboembolism (EINSTEIN-Jr): results from three multicentre, single-arm, phase 2 studies 137
K-dependent coagulant and anticoagulant factors deficiency in late haemorrhagic disease of the newborn 137
Thrombin generation in children with acute lymphoblastic leukemia: effect of leukemia immunophenotypic subgroups 136
Clinical Data of Neonatal Systemic Thrombosis 135
Mechanisms of enhanced osteoclastogenesis in Alkaptonuria 134
Iodine absorption in celiac children: A longitudinal pilot study 134
Analisi di Parametri di Coagulazione e Fibrinolisi in Bambini ed Adolescenti Obesi 133
Preventing and Treating Colic 133
Chronic immune thrombocytopenia in childhood 132
Hepatic angiodynamic profile in paediatric patients with hereditary haemorrhagic telangiectasia type 1 and type 2 132
Sport and Children with Immune Thrombocytopenia: Never Give Up 132
Thrombin activation in thalassemia major: effect of iron chelators and splenectomy 131
ANKRD26-related thrombocytopenia and myeloid malignancies. 131
Rituximab unveils hypogammaglobulinemia and immunodeficiency in children with autoimmune cytopenia 131
Echovirus 11 lineage I and other enteroviruses in hospitalized children with acute respiratory infection in Southern Italy, 2022-2023 130
APC resistance in thalassemic patients 130
Autoimmune haematological disorders in two Italian children with Kabuki Syndrome 130
Anomalie cellulari e plasmatiche della coagulazione e della fibrinolisi dei linfomi ed effetto della terapia 130
Acute childhood idiopathic thrombocytopenic purpura: AIEOP consensus guidelines for diagnosis and treatment 130
Analysis of coagulation and fibrinolysis parameters in obese children and adolescents 130
Thromboembolic risk in children with nephrotic syndrome 129
Rituximab (anti-CD20 monoclonal antibody) in children with chronic refractory symptomatic immune thrombocytopenic purpura: efficacy and safety of treatment 128
ROLE OF ANTITHYROID AUTOIMMUNITY AS A PREDICTIVE BIOMARKER OF CHRONIC IMMUNE THROMBOCYTOPENIA 127
Catheter-related infections in pediatric patients with cancer. 126
ITP-QoL Questionnaire for Children with Immune Thrombocytopenia: Italian Version validation's 126
Long-term follow-up analysis after rituximab therapy in children with refractory symptomatic ITP: identification of factors predictive of a sustained response 126
Analisi di parametri di coagulazione e fibrinolisi in bambini e adolescenti obesi 126
Basi genetiche della trombosi in età neonatale (analisi della prevalenza di 4 fattori di rischio nella popolazione italiana) 126
Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial 126
Coagulation and fibrinolytic systems in the ill preterm newborn 125
Present and Future of Pediatric Hemophilia Treatment 125
Resistance to activated protein C in thalassaemic patients: an underlying cause of thrombosis 125
Thromboembolic risk in children with nephrotic syndrom. 124
Guidelines for the use of long-term central venous catheter in children with hemato-oncological disorders. On behalf of supportive therapy working group of Italian Association of Pediatric Hematology and Oncology (AIEOP) 124
Protein C deficiency in two children with cerebral thrombosis 124
La proteina Z e i PIVKA II in età neonatale 123
Cellular and plasmatic anomalies of the coagulation system and fibrinolysis in children with lymphomas and influence of cytostatic treatment 123
Therapeutic management and costs of severe haemophilia A patients with inhibitors in Italy 123
Coagulation inhibitors (PC and ATIII) in preterm infants during the first month of life 122
Alterazioni dell'equilibrio coagulativo-fibrinolitico dei monociti e della capacità fibrinolitica plasmatica dei linfomi 122
Perceived well-being and mental health in haemophilia 122
Totale 15.306
Categoria #
all - tutte 174.124
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 174.124


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.866 149 523 46 187 82 108 115 182 154 114 457 749
2022/20233.974 625 381 250 367 502 521 59 420 645 28 95 81
2023/20241.356 116 282 72 146 113 324 41 50 26 37 19 130
2024/20256.443 178 103 668 217 166 565 407 510 297 348 1.038 1.946
2025/202613.059 1.805 565 812 1.441 1.357 663 1.517 410 1.257 1.203 438 1.591
2026/2027282 282 0 0 0 0 0 0 0 0 0 0 0
Totale 42.040